Instruction for use: Rhinonorm

Active substance: Xylometazoline

ATX Code R01AA07 Xylometazoline

Pharmacotherapeutic group:

Alpha-adrenoceptor agonists

decongestant

The nosological classification (ICD-10)

H66.9 Otitis media, unspecified

Chronic otitis, Otitis, otitis media, middle ear infections, Otitis media in children

H68 inflammation and blockage of the ear [Eustachian] pipes

Eustachian, acute evstahiit, Qatar Eustachian tubes, Evstaheit

J00 Acute nasopharyngitis [runny nose]

Viral rhinitis, Inflammation of the nasopharynx, Inflammatory diseases of the nose, purulent rhinitis, Nasal congestion, Nasal congestion with colds and flu, The difficulty of nasal breathing, The difficulty of nasal breathing for colds, Difficulty in nasal breathing, Difficulty in nasal breathing in colds, nasal, hypersecretion, cold, ARI with rhinitis phenomena, coryza, Acute rhinitis of various origins, Acute rhinitis with thick purulent mucous exudate, Acute nasopharyngitis, Swelling of the mucosa of the nasopharynx, Rhinitis, rhinorrhea, Infectious-inflammatory diseases of ENT organs, heavy cold, rhinopharyngitis, nasopharyngitis

J01 Acute sinusitis

Inflammation of the sinuses, Inflammatory diseases of the paranasal sinuses, Purulent inflammation of the paranasal sinuses, Infectious-inflammatory diseases of ENT organs, Infection of the sinuses, Combined sinusitis, Exacerbation of sinusitis, Acute inflammation of the paranasal sinuses, Acute bacterial sinusitis, Acute sinusitis in adults, Subacute sinusitis, acute Sinusitis, sinusitis

J30 Vasomotor and allergic rhinitis

Allergic rinopatiya, Allergic rhinosinusopathy, Allergic respiratory diseases, Allergic rhinitis, nasal allergy, Seasonal Allergic Rhinitis, Vasomotor rhinitis, Long-allergic rhinitis, Perennial allergic rhinitis, Perennial allergic rhinitis, Year-round or seasonal allergic rhinitis, Year-round allergic rhinitis nature, Rhinitis allergic vasomotor, Exacerbation of pollen allergy in the form of Syndrome rinokonyunktivalnogo, Acute allergic rhinitis, Edema of the nasal mucosa, Edema of the nasal mucosa, Swelling of the mucosa of the nasal cavity, Swelling of the nasal mucosa, Swelling of the nasal mucosa, pollen disease, Permanent allergic rhinitis, rhinoconjunctivitis, rhinosinusitis,rhinosinusopathy, Seasonal allergic rhinitis, Seasonal Allergic Rhinitis, Haymarket rhinitis, Chronic allergic rhinitis, Allergic respiratory diseases

J32 Chronic sinusitis

Allergic rhinosinusopathy, purulent sinusitis, Catarrh nasopharyngeal area, Catarrh of the sinuses, Exacerbation of sinusitis, chronic Sinusitis

J999 * Diagnosis of Respiratory Diseases

bronchography, bronchoscopy, Diagnostic procedures in the nasal passages, Diagnostic Study of the bronchi, laryngoscopy, Preparing for rhinoscopy, Preparing the patient for bronchoscopy and / or bronhografii, Preparing the patient for bronchoscopy or bronhografii, Preparing the patient for diagnostic procedures in the nasal passages, Preparing the patient for diagnostic procedures in the area of the nasal passages, rhinoscopy, Visualization of the chest cavity, Chest X-ray, Mediastinoscopy

Composition

nasal spray, at a dose of 10 ml

active substance:

xylometazoline hydrochloride 10 mg

Excipients: citric acid monohydrate; sodium citrate dihydrate; 85% glycerol; water for injections

Sprey nasal dose (for children), 10 ml

active substance:

xylometazoline hydrochloride 5 mg

Excipients: citric acid monohydrate; sodium citrate dihydrate; 85% glycerol; water for injections

pharmachologic effect

antikongestat, vasoconstrictor

Dosage and Administration

Intranasal.

Adults and children over 10 years: Rinonorm, metered dose nasal spray, 0.1% - 1 dose in each nostril no more than 3 times a day.

Children from 2 to 10 years: Rinonorm, nasal spray dosage (for children), 0.05% - 1 dose in each nostril no more than 3 times a day.

Maximum number of applications should not exceed 7 times a day. The interval between administration of the drug should not be less than 6 hours.

1 dose (one push on the piston unit) = 0.14 ml.

To avoid complications in a resumption of symptoms, duration of continuous use of the drug should not exceed 7 days.

empty the nasal passage from a secret, and during administration of the drug is necessary to make an easy breath through your nose before use Rinonorm drug.

release Form

Spray nasal dosage, 0.1%. 10 or 15 ml of a dark glass vial with a metering device for spraying for nozzle protection cap and the nose. On 1 vial. in a cardboard bundle.

Spray nasal dosage (for children), 0.05%. 10 or 15 ml of a dark glass vial with a metering device for spraying for nozzle protection cap and the nose. On 1 vial. in a cardboard bundle.

Storage conditions of Rhinonorm

The temperature is not higher than 25 ° C.

Keep out of the reach of children.
Shelf life of Rhinonorm

nasal spray for children 0.05% - 3 years. After opening the bottle - 1 year.

nasal spray dosage of 0.1% - 3 years.

Do not use beyond the expiration date printed on the package.

Available without prescription